Drug Type Small molecule drug |
Synonyms BLX-0676 |
Target |
Mechanism PIM1 inhibitors(Proto-oncogene serine/threonine-protein kinase Pim-1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Multiple Myeloma | Preclinical | US | Biolexis TherapeuticsStartup | 29 Sep 2022 |
Primary Myelofibrosis | Preclinical | US | Biolexis TherapeuticsStartup | 29 Sep 2022 |